Internal Medicine Alert - July 30, 2006

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/06. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of this issue.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine
UCLA School of Medicine

Malcolm Robinson, MD, FACP, FACG
Emeritus Clinical Professor of Medicine
University of Oklahoma College of Medicine
Oklahoma City

Joseph Varon, MD, FACP, FCCP, FCCM
Professor
University of Texas Health Science Center
Houston;
St. Luke?s Episcopal Hospital
Houston

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Author
Dara Jamieson, MD
Associate Professor
Clinical Neurology
Weill Medical College
Cornell University

Subjects:

  • Hepatitis C: A Scourge of the Baby Boomers?
  • Risk of Death and AMI in Apparently Healthy Subjects with Ventricular Arrhythmias
  • Low-dose Aspirin and Endoscopic Gastric and Duodenal Ulcer Rates in Users of NSAIDs or COX-2 inhibitors
  • The Pressure of Air Travel: Headaches on the Plane
  • Many Factors are Responsible for Treatment Outcome in Acute Exacerbations of Chronic Bronchitis
  • Zoster Vaccine Live (Oka/Merck)
  • Clinical Briefs By Louis Kuritzky, MD

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert's Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, associate editors Mary Elina Ferris, MD, Harold L. Karpman, MD, FACC, FACP, Joseph Varon, MD, FACP, FCCP, FCCM, James Chan, PharmD, PhD, and William T. Elliott, MD, FACP report no financial relationship to this field of study. Associate editor Malcolm Robinson, MD, FACP, FACG serves as a consultant for TAP, Pfizer, Janssen, Eisai, J&J-Merck, and Procter & Gamble, is on the speaker’s bureau of Janssen, Eli Lilly, Solvay, TAP, and Aventis, and does research for Forest Labs, Wyeth-Ayerst, AstraZeneca, and Centocor. Author Dara Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker’s bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer. Associate editor Louis Kuritzky, MD is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.